tradingkey.logo
搜索

Zimmer Biomet Holdings Inc

ZBH
添加自选
91.210USD
-1.890-2.03%
收盘 06/29, 16:00美东报价延迟15分钟
17.83B总市值
23.59市盈率 TTM

Zimmer Biomet Holdings Inc

91.210
-1.890-2.03%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-2.03%

5天

+4.73%

1月

+10.79%

6月

+0.75%

今年开始到现在

+1.43%

1年

-0.27%

关键数据
92.880今开
92.880最高
1.91M成交量
23.59市盈率 TTM
10.28市盈率动
0.960股息TTM
0.98%换手率
93.100昨收
91.110最低
78.56M成交额
19.73市盈率静
1.40市净率
1.05%股息率 TTM
3.39%ROA
108.29052周最高
0.92量比
903.80M净利润
195.50M总股本
3.8671每股收益TTM
0.48Beta
6.07%ROE
79.12052周最低
1.90%振幅
64.62%毛利率
17.83B总市值
8.90回报/风险
1.47%风险率

TradingKey Zimmer Biomet Holdings Inc股票评分

单位: USD 更新时间: 2026-06-29

操作建议

Zimmer Biomet Holdings Inc当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名17/204位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价98.87。中期看,股价处于平稳状态。近一个月,市场表现较强,技术面和基本面综合得分较高,较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Zimmer Biomet Holdings Inc评分

相关信息

行业排名
17 / 204
全市场排名
72 / 4570
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Zimmer Biomet Holdings Inc亮点

亮点风险
Zimmer Biomet Holdings, Inc. is a global medical technology company. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. It also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.
高分红
公司属于高分红公司,最新股息支付率21.51%
估值合理
公司最新PE估值23.59,处于3年历史合理位
罗伯特·奥尔斯坦持仓
明星投资者罗伯特·奥尔斯坦持仓,最新持仓市值95.32K

分析师目标

根据 30 位分析师
持有
评级
98.869
目标均价
+6.20%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Zimmer Biomet Holdings Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Zimmer Biomet Holdings Inc简介

Zimmer Biomet Holdings, Inc. is a global medical technology company. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. It also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.
公司代码ZBH
公司Zimmer Biomet Holdings Inc
CEOTornos (Ivan)
网址https://www.zimmerbiomet.com/en

常见问题

Zimmer Biomet Holdings Inc(ZBH)的当前股价是多少?

Zimmer Biomet Holdings Inc(ZBH)的当前股价是 91.21。

Zimmer Biomet Holdings Inc的股票代码是什么?

Zimmer Biomet Holdings Inc的股票代码是ZBH。

Zimmer Biomet Holdings Inc股票的52周最高点是多少?

Zimmer Biomet Holdings Inc股票的52周最高点是108.29。

Zimmer Biomet Holdings Inc股票的52周最低点是多少?

Zimmer Biomet Holdings Inc股票的52周最低点是79.12。

Zimmer Biomet Holdings Inc的市值是多少?

Zimmer Biomet Holdings Inc的市值是17.83B。

现在Zimmer Biomet Holdings Inc(ZBH)的股票是买入、持有还是卖出?

根据分析师评级,Zimmer Biomet Holdings Inc(ZBH)的总体评级为signal_hold,目标价格为98.87。

Zimmer Biomet Holdings Inc(ZBH)股票的每股收益(EPS TTM)是多少

Zimmer Biomet Holdings Inc(ZBH)股票的每股收益(EPS TTM)是3.56。
KeyAI